136 related articles for article (PubMed ID: 28007074)
1. Effect of Stent Implantation on the Deformations of the Superficial Femoral Artery and Popliteal Artery: In Vivo Three-Dimensional Deformational Analysis from Two-Dimensional Radiographs.
Schumann S; Gökgöl C; Diehm N; Büchler P; Zheng G
J Vasc Interv Radiol; 2017 Jan; 28(1):142-146. PubMed ID: 28007074
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Quantification of the Deformations of the Femoropopliteal Segment: Percutaneous Transluminal Angioplasty vs Nitinol Stent Placement.
Gökgöl C; Schumann S; Diehm N; Zheng G; Büchler P
J Endovasc Ther; 2017 Feb; 24(1):27-34. PubMed ID: 28095767
[TBL] [Abstract][Full Text] [Related]
3. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
[TBL] [Abstract][Full Text] [Related]
4. Early Supera stent fracture in the femoropopliteal artery.
Kim HT; Cho JH; Lee JH; Kim U
Cardiovasc J Afr; 2020 May/Jun 23; 31(3):e1-e3. PubMed ID: 32181793
[TBL] [Abstract][Full Text] [Related]
5. Deformation of the Femoropopliteal Segment: Effect of Stent Length, Location, Flexibility, and Curvature.
Ní Ghriallais R; Heraty K; Smouse B; Burke M; Gilson P; Bruzzi M
J Endovasc Ther; 2016 Dec; 23(6):907-918. PubMed ID: 27647689
[TBL] [Abstract][Full Text] [Related]
6. Impact of Drug-Eluting Stent Implantation for Femoropopliteal In-Stent Occlusion.
Tomoi Y; Soga Y; Iida O; Shiraki T; Kobayashi Y; Hiramori S; Ando K
J Endovasc Ther; 2016 Jun; 23(3):461-7. PubMed ID: 27004496
[TBL] [Abstract][Full Text] [Related]
7. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
[TBL] [Abstract][Full Text] [Related]
8. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year.
Davaine JM; Quérat J; Guyomarch B; Brennan MÁ; Costargent A; Chaillou P; Patra P; Gouëffic Y
Eur J Vasc Endovasc Surg; 2013 Aug; 46(2):201-12. PubMed ID: 23773773
[TBL] [Abstract][Full Text] [Related]
9. Quantification of popliteal artery deformation during leg flexion in subjects with peripheral artery disease: a pilot study.
Gökgöl C; Diehm N; Kara L; Büchler P
J Endovasc Ther; 2013 Dec; 20(6):828-35. PubMed ID: 24325701
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
[TBL] [Abstract][Full Text] [Related]
11. Intravascular ultrasound measurements after drug-eluting stent placement in femoropopliteal lesions: determining predictors of restenosis.
Mori S; Hirano K; Nakano M; Muramatsu T; Tsukahara R; Ito Y; Ishimori H
J Endovasc Ther; 2015 Jun; 22(3):341-9. PubMed ID: 25862363
[TBL] [Abstract][Full Text] [Related]
12. The use of the GORE® TIGRIS® Vascular Stent with dual component design in the superficial femoral and popliteal arteries at 6 months.
Piorkowski M; Freitas B; Schmidt A; Bräunlich S; Ulrich M; Schuster J; Bausback Y; Werner M; Scheinert D
J Cardiovasc Surg (Torino); 2013 Aug; 54(4):447-53. PubMed ID: 24013533
[TBL] [Abstract][Full Text] [Related]
13. Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study.
Murata N; Takahara M; Soga Y; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Yokoi H; Tosaka A; Tanaka N; Iida O
J Endovasc Ther; 2016 Aug; 23(4):642-7. PubMed ID: 27099284
[TBL] [Abstract][Full Text] [Related]
14. Treatment of the femoropopliteal artery with the bioresorbable REMEDY stent.
Bontinck J; Goverde P; Schroë H; Hendriks J; Maene L; Vermassen F
J Vasc Surg; 2016 Nov; 64(5):1311-1319. PubMed ID: 27462002
[TBL] [Abstract][Full Text] [Related]
15. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial.
Laird JR; Katzen BT; Scheinert D; Lammer J; Carpenter J; Buchbinder M; Dave R; Ansel G; Lansky A; Cristea E; Collins TJ; Goldstein J; Cao AY; Jaff MR;
J Endovasc Ther; 2012 Feb; 19(1):1-9. PubMed ID: 22313193
[TBL] [Abstract][Full Text] [Related]
16. Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial.
Laird JR; Jain A; Zeller T; Feldman R; Scheinert D; Popma JJ; Armstrong EJ; Jaff MR;
J Endovasc Ther; 2014 Apr; 21(2):202-12. PubMed ID: 24754279
[TBL] [Abstract][Full Text] [Related]
17. Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents.
Chan YC; Cheng SW; Ting AC; Cheung GC
J Vasc Surg; 2014 Feb; 59(2):384-91. PubMed ID: 24461862
[TBL] [Abstract][Full Text] [Related]
18. Femoropopliteal atherosclerosis: do drug-eluting stents improve outcome?
Micari A; Nerla R; Cremonesi A
J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e91-e92. PubMed ID: 29538151
[No Abstract] [Full Text] [Related]
19. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease.
Chan YC; Cheng SW; Cheung GC
J Vasc Surg; 2015 Nov; 62(5):1201-9. PubMed ID: 26169015
[TBL] [Abstract][Full Text] [Related]
20. Drug-Coated Balloons for Complex Femoropopliteal Lesions: 2-Year Results of a Real-World Registry.
Schmidt A; Piorkowski M; Görner H; Steiner S; Bausback Y; Scheinert S; Banning-Eichenseer U; Staab H; Branzan D; Varcoe RL; Scheinert D
JACC Cardiovasc Interv; 2016 Apr; 9(7):715-24. PubMed ID: 27056311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
